Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Guerbet Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (79)
Cancellation by sponsor (32)
Prescription medicine registration (3)
Section 14, TGO91 consent (3)

Date

2025 (32)
2023 (3)
2022 (2)
2021 (7)
2020 (8)
2019 (4)
2018 (8)
2017 (8)
2016 (8)
2015 (1)
2014 (1)
2013 (1)
2010 (3)
2004 (1)
2003 (3)
2000 (5)
1999 (1)
1997 (2)
1995 (2)
1994 (12)
1993 (2)
1991 (3)

Search

Sponsor content

117 result(s) found, displaying 91 to 100

DOTAREM gadoteric acid 279.32mg/mL injection 10mL vial (76925)

11 December 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DOTAREM gadoteric acid 279.32mg/mL injection 10mL vial.
DOTAREM gadoteric acid 279.32mg/mL injection 5mL vial (76926)

11 December 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DOTAREM gadoteric acid 279.32mg/mL injection 5mL vial.
DOTAREM gadoteric acid 279.32mg/mL injection 20mL vial (76923)

11 December 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DOTAREM gadoteric acid 279.32mg/mL injection 20mL vial.
DOTAREM gadoteric acid 279.32mg/mL injection 15mL vial (76924)

11 December 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DOTAREM gadoteric acid 279.32mg/mL injection 15mL vial.
OPTIRAY 320 ULTRAJECT ioversol 50.8g/75mL injection syringe (73580)

6 April 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OPTIRAY 320 ULTRAJECT ioversol 50.8g/75mL injection syringe.
OPTIRAY 350 Ioversol 74% w/v 55.575g/75mL injection syringe (70059)

16 July 1999

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OPTIRAY 350 Ioversol 74% w/v 55.575g/75mL injection syringe.
OPTIRAY 350 Ioversol 74.1g/100mL injection syringe (61983)

10 November 1997

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OPTIRAY 350 Ioversol 74.1g/100mL injection syringe.
OPTIRAY 350 Ioversol 92.6g/125mL injection syringe (61984)

10 November 1997

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OPTIRAY 350 Ioversol 92.6g/125mL injection syringe.
OPTIRAY 350 ULTRAJECT Ioversol 74% w/v 37.05g/50mL injection syringe (51796)

21 April 1995

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OPTIRAY 350 ULTRAJECT Ioversol 74% w/v 37.05g/50mL injection syringe.
OPTIRAY 350 ULTRAJECT Ioversol 74% w/v 22.23g/30mL injection syringe (51795)

21 April 1995

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OPTIRAY 350 ULTRAJECT Ioversol 74% w/v 22.23g/30mL injection syringe.

Pages

First page
Previous page
…
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.